Author | Sanjay J. Mathew, MD


Revisiting the Hallucinogenic Potential of Ketamine

June 26, 2018


An exploration of findings from contemporary research that hint at the unexplored hallucinogenic potential of ketamine and considerations for future investigation.

Ketamine for Treatment-Resistant Unipolar Depression: Current Evidence

September 30, 2014


The discovery that a single IV infusion of low-dose (subanesthetic) ketamine exerts rapid antidepressant effects constitutes an expansion in our understanding of the neurobiology of depression and provides new avenues for drug development.